Magnetic Resonance Imaging–Based Radiomics Nomogram to Predict Intraoperative Hemorrhage of Placenta Previa

Abstract

Objective Placenta previa (PP) is associated with intraoperative and postpartum hemorrhage, increased maternal morbidity and mortality. We aimed to develop a magnetic resonance imaging (MRI)-based nomogram to preoperative prediction of intraoperative hemorrhage (IPH) for PP.

Study Design A total of 125 PP pregnant women were divided into a training set (n = 80) and a validation set (n = 45). An MRI-based model was built for the classification of patients into IPH and non-IPH groups in a training set and a validation set. Multivariate nomograms were built according to radiomics features. Receiver operating characteristic (ROC) curve was used to assess the model. Predictive accuracy of nomogram were assessed by calibration plots and decision curve analysis.

Results In multivariate analysis, placenta position, placenta thickness, cervical blood sinus, and placental signals in the cervix were significantly independent predictors for IPH (all ps < 0.05). The MRI-based nomogram showed favorable discrimination between IPH and non-IPH groups. The calibration curve showed good agreement between the estimated and the actual probability of IPH. Decision curve analysis also showed a high clinical benefit across a wide range of probability thresholds. Area under the ROC curve was 0.918 (95% confidence interval [CI]: 0.857–0.979) in the training set and 0.866 (95% CI: 0.748–0.985) in the validation set by the combination of four MRI features.

Conclusion The MRI-based nomograms might be a useful tool for the preoperative prediction of IPH outcomes for PP. Our study enables obstetricians to perform adequate preoperative evaluation to reduce blood loss and cesarean hysterectomy.

Key Points

• MRI is an important method for preoperative assessment of the risk of placenta previa.

• MRI-based nomogram can assess the risk of intraoperative bleeding of placenta previa.

• MRI is helpful for more comprehensive evaluation of placenta previa and adequate preoperative preparation.

Keywords

placenta previa - magnetic resonance imaging - intraoperative hemorrhage - nomogram

• References

• 1 Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol 2015; 126 (03) 654-668
• 2 Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 2003; 13 (03) 175-190
• 3 Iacovelli A, Liberati M, Khalil A. et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33 (03) 471-481
• 4 Carusi DA. The placenta accreta spectrum: epidemiology and risk factors. Clin Obstet Gynecol 2018; 61 (04) 733-742
• 5 Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107 (04) 927-941
• 6 Ghourab S. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome?. Ultrasound Obstet Gynecol 2001; 18 (02) 103-108
• 7 Fadl S, Moshiri M, Fligner CL, Katz DS, Dighe M. Placental imaging: normal appearance with review of pathologic findings. Radiographics 2017; 37 (03) 979-998
• 8 Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 2007; 25 (01) 87-93
• 9 Arthuis C, Millischer AE, Bussières L. et al. MRI based morphological examination of the placenta. Placenta 2021; 115 (115) 20-26
• 10 Fratelli N, Fichera A, Prefumo F. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders. Curr Opin Obstet Gynecol 2022; 34 (05) 287-291
• 11 Kollmann M, Gaulhofer J, Lang U, Klaritsch P. Placenta praevia: incidence, risk factors and outcome. J Matern Fetal Neonatal Med 2016; 29 (09) 1395-1398
• 12 Faranesh R, Romano S, Shalev E, Salim R. Suggested approach for management of placenta percreta invading the urinary bladder. Obstet Gynecol 2007; 110 (2 Pt 2): 512-515
• 13 Onwere C, Gurol-Urganci I, Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. Maternal morbidity associated with placenta praevia among women who had elective caesarean section. Eur J Obstet Gynecol Reprod Biol 2011; 159 (01) 62-66
• 14 Schneiderman M, Balayla J. A comparative study of neonatal outcomes in placenta previa versus cesarean for other indication at term. J Matern Fetal Neonatal Med 2013; 26 (11) 1121-1127
• 15 Kim JW, Lee YK, Chin JH. et al. Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis. J Anesth 2017; 31 (04) 593-600
• 16 Chong Y, Zhang A, Wang Y, Chen Y, Zhao Y. An ultrasonic scoring system to predict the prognosis of placenta accreta: a prospective cohort study. Medicine (Baltimore) 2018; 97 (35) e12111
• 17 Kingdom JC, Hobson SR, Murji A. et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020. Am J Obstet Gynecol 2020; 223 (03) 322-329
• 18 Chen D, Xu J, Ye P. et al. Risk scoring system with MRI for intraoperative massive hemorrhage in placenta previa and accreta. J Magn Reson Imaging 2020; 51 (03) 947-958
• 19 D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44 (01) 8-16
• 20 Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet 2018; 140 (03) 274-280
• 21 Hou S, Song Y, Wu J. et al. Comparison of magnetic resonance imaging of the lower uterine segment in pregnant women with central placenta previa with and without placenta accreta spectrum from a single center. Med Sci Monit 2021; 27: e932759
• 22 Badr DA, Al Hassan J, Salem Wehbe G, Ramadan MK. Uterine body placenta accreta spectrum: a detailed literature review. Placenta 2020; 95 (95) 44-52
• 23 Bauer ST, Bonanno C. Abnormal placentation. Semin Perinatol 2009; 33 (02) 88-96
• 24 Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
• 25 D'Arpe S, Franceschetti S, Corosu R. et al. Emergency peripartum hysterectomy in a tertiary teaching hospital: a 14-year review. Arch Gynecol Obstet 2015; 291 (04) 841-847
• 26 Rahaim NS, Whitby EH. The MRI features of placental adhesion disorder and their diagnostic significance: systematic review. Clin Radiol 2015; 70 (09) 917-925
• 27 Hashem LB, Salem DS, Hamed ST. et al. Role of MRI versus ultrasound in the assessment of placental abnormalities and diseases. Egypt J Radiol Nucl Med 2016; 47 (02) 641-658
• 28 Romeo V, Verde F, Sarno L. et al. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings. Radiol Med (Torino) 2021; 126 (09) 1216-1225
• 29 Baughman WC, Corteville JE, Shah RR. Placenta accreta: spectrum of US and MR imaging findings. Radiographics 2008; 28 (07) 1905-1916
• 30 Ueno Y, Kitajima K, Kawakami F. et al. Novel MRI finding for diagnosis of invasive placenta praevia: evaluation of findings for 65 patients using clinical and histopathological correlations. Eur Radiol 2014; 24 (04) 881-888
• 31 Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019; 146 (01) 20-24